文传商讯
Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator
2021-09-24 19:23:46
GARP Survey Finds Significant Increases in Use of Scenario Analysis to Manage Climate Change Risk
2021-09-17 10:14:28
Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS
2021-09-17 10:14:28
Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of spar
2021-09-16 16:07:28
